Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01496963
What this trial is testing

Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

Who this might be right for
Thalassemia MajorThalassemia IntermediaPulmonary Arterial Hypertension
Ente Ospedaliero Ospedali Galliera 1,500
Very early researchStudy completedNCT03655704
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

Who this might be right for
Pulmonary Arterial Hypertension
Steeve Provencher 7
Testing effectiveness (Phase 2)Study completedNCT01553721
What this trial is testing

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Dong-A ST Co., Ltd. 63
Large-scale testing (Phase 3)Looking for participantsNCT04062565
What this trial is testing

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

Who this might be right for
Pulmonary Arterial Hypertension
University of Arizona 20
Post-approval studies (Phase 4)Study completedNCT01338636
What this trial is testing

An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Exercise-induced Pulmonary Arterial Hypertension
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02911844
What this trial is testing

Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 5
Not applicableStudy completedNCT06543745
What this trial is testing

Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionFrailty
University of Pennsylvania 19
Testing effectiveness (Phase 2)Looking for participantsNCT04778046
What this trial is testing

Pulmonary Hypertension SOLAR

Who this might be right for
Interstitial Lung DiseaseCOPDPulmonary Arterial Hypertension
Bastiaan Driehuys 30
Not applicableStudy completedNCT02961023
What this trial is testing

The Effect of Adding Exercise Training to Optimal Therapy in PAH

Who this might be right for
Pulmonary Arterial Hypertension
National Health Service, United Kingdom 30
Post-approval studies (Phase 4)Study completedNCT00373360
What this trial is testing

Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin

Who this might be right for
Pulmonary Hypertension
United Therapeutics 10
Not applicableStudy completedNCT01799473
What this trial is testing

Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 98
Not applicableEnded earlyNCT00722254
What this trial is testing

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

Who this might be right for
Primary MyelofibrosisPrimary Pulmonary HypertensionSecondary Myelofibrosis+1 more
University of Utah 15
Post-approval studies (Phase 4)Study completedNCT00617305
What this trial is testing

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 38
Large-scale testing (Phase 3)Study completedNCT02007629
What this trial is testing

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

Who this might be right for
Hypertension, Pulmonary
Bayer 61
Not applicableStudy completedNCT03928002
What this trial is testing

4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease

Who this might be right for
Congenital Heart DiseasePulmonary Arterial Hypertension
Centre Chirurgical Marie Lannelongue 50
Early research (Phase 1)Study completedNCT00240656
What this trial is testing

Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Hebei Medical University
Post-approval studies (Phase 4)Study completedNCT01462565
What this trial is testing

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03492177
What this trial is testing

A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 63
Large-scale testing (Phase 3)Ended earlyNCT01204853
What this trial is testing

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

Who this might be right for
Hypertension, Pulmonary
Pfizer 2
Testing effectiveness (Phase 2)Ended earlyNCT03795428
What this trial is testing

Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 25
Next Page